Skip to main content
. 2021 Oct 27;13(21):24086–24100. doi: 10.18632/aging.203652

Figure 1.

Figure 1

Identification of DEGS in AD. (A) The expression of 19 m6A modification-related genes in GSE33000. (B) IGF2BP2 expression in AD patients and in normal people in GSE33000. (C) IGF2BP2 expression in AD patients and in normal people in GSE48350 and GSE5281. (D) IGF2BP2 expression in different brain regions of AD patients in GSE33000.